TokenPost·
Pelthos Therapeutics Shares Fall About 35% After Castle Creek Merger Deal
The reported share price was $10.79. The proposed combination would add cell and gene therapies for serious skin diseases to Pelthos’ portfolio.
More news
- TokenPostVIX Rises Above 20 as U.S. Stocks Sell Off and Risk Aversion Grows
- TokenPostBinance Co-Founder He Yi Pledges More Security After Wallet Theft
- TokenPostThe Bancorp Sets 2027 Core EPS at $7.00-$7.20, Previews 2028 Core EPS
- TokenPostKosmos Energy Schedules Third-Quarter Results for Nov. 2
- TokenPostPublic Service Enterprise Group Q3 Consensus Puts EPS at $1.19
- Crypto BriefingGoogle’s Suncatcher satellite sends first AI-generated haiku from orbit